Bivalent Degrader Landscape Webinar
In this webinar, we took a deep dive into the increasingly evolving landscape, and explored the dynamics surrounding PROTACS, emerging bivalent degrader targets, and the spectrum of cancer and non-cancer indications. We examined the trajectory of this field amidst the influx of investments, shedding light on its evolution and potential future directions. Watch the recording now.
You May Also Be Interested In…
What is Beacon?
Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.
Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.
This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.
We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!
